Showing results (141-150 of 499) with videos related to
Sort By:
Pageof 50
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 26, 2006
Presentation of tumor antigens by dendritic cells genetically modified with viral and nonviral vectorsMichal Lotem, Yangbing Zhao, John Riley, et al.The Journal of Clinical Investigation|October 15, 2019
Recognition of human gastrointestinal cancer neoantigens by circulating PD-1+ lymphocytesAlena Gros, Eric Tran, Maria R Parkhurst, et al.Cancer Research|April 19, 2007
Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bondCyrille J Cohen, Yong F Li, Mona El-Gamil, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 2, 2007
Persistence of tumor infiltrating lymphocytes in adoptive immunotherapy correlates with telomere lengthXinglei Shen, Juhua Zhou, Karen S Hathcock, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 2012
Local delivery of interleukin-12 using T cells targeting VEGF receptor-2 eradicates multiple vascularized tumors in miceDhanalakshmi Chinnasamy, Zhiya Yu, Sid P Kerkar, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2005
Recognition of fresh human tumor by human peripheral blood lymphocytes transduced with a bicistronic retroviral vector encoding a murine anti-p53 TCRCyrille J Cohen, Zhili Zheng, Regina Bray, et al.Blood|July 18, 2013
Expression profiling of TCR-engineered T cells demonstrates overexpression of multiple inhibitory receptors in persisting lymphocytesDaniel Abate-Daga, Ken-ichi Hanada, Jeremy L Davis, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 17, 2012
Simplified method of the growth of human tumor infiltrating lymphocytes in gas-permeable flasks to numbers needed for patient treatmentJianjian Jin, Marianna Sabatino, Robert Somerville, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2010
Development of human anti-murine T-cell receptor antibodies in both responding and nonresponding patients enrolled in TCR gene therapy trialsJeremy L Davis, Marc R Theoret, Zhili Zheng, et al.Human Gene Therapy Methods|November 30, 2016
A Rapid Cell Expansion Process for Production of Engineered Autologous CAR-T Cell TherapiesTangying Lily Lu, Omar Pugach, Robert Somerville, et al.Pageof 50